Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols.

Leukemia & lymphoma - 1 Sept 2004

Matthews Christine, Catherwood Mark, Morris T C M 'Curly', Alexander H Denis

Abstract excerpt

Current methods for the detection of IgVH mutational status in chronic lymphocytic leukemia (CLL), which identifies 2 subgroups of patients with significantly different outcomes, are laborious, expensive and do not lend themselves to a routine diagnostic setting. With the introduction of BIOMED-2 primers, a rapid protocol is now available. This study evaluated the protocol by examining DNA from 100 CLL patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Primers

Share to Immunoglobulin Heavy Chains

Share to Immunoglobulin Variable Region

Share to In Situ Hybridization, Fluorescence

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Reference Standards

Source

Identifiers

PMID: 15223652
DOI: 10.1080/10428190410001710812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols.PMID 15223652Read ↗

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLLSemantic proximity Read ↗

Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.Semantic proximity Read ↗

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencingSemantic proximity Read ↗

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendationsSemantic proximity Read ↗

Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.Semantic proximity Read ↗

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.Semantic proximity Read ↗

Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones.Semantic proximity Read ↗

5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.Semantic proximity Read ↗

IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patientsSemantic proximity Read ↗

BIOMED-2 Multiplex Immunoglobulin/T-Cell Receptor Polymerase Chain Reaction Protocols Can Reliably Replace Southern Blot Analysis in Routine Clonality DiagnosticsSemantic proximity Read ↗

IGHV mutational status testing in chronic lymphocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.